Brady (BRC) Sidoti Small-Cap Virtual Investor Conference summary
Event summary combining transcript, slides, and related documents.
Sidoti Small-Cap Virtual Investor Conference summary
18 Jun, 2026Company overview and product portfolio
Specializes in high-performance specialty adhesives and printing solutions for safety and identification applications across diverse end markets.
Product categories include safety and facility identification, wire identification, product ID, healthcare ID, and people ID, with no single customer accounting for more than 10% of sales.
48% of revenue is generated outside the U.S., reflecting a diversified global presence.
Recent acquisitions (Gravotech and MECCO) expanded capabilities into direct part marking, filling a previous product gap.
Financial performance and capital allocation
Achieved five consecutive years of record adjusted EPS, with 2025 up 9% over the prior year.
Maintains a strong balance sheet with a net cash position of $149 million as of April 30th.
Consistently returns capital to shareholders through dividends (40 consecutive annual increases) and share buybacks.
Organic sales growth has been positive for five straight years, with a 4.3% increase year-to-date through Q3.
Operational efficiency and investment in innovation
R&D investment reached an all-time high of 5.3% of sales in 2025 and is set to increase further.
SG&A as a percentage of sales reduced by 800 basis points over eight years, with ongoing efficiency projects and automation.
Gross profit margins exceeded 50% in 2024 and 2025, driven by high-margin engineered products and operational improvements.
Cash flow from operations increased 34% through the first three quarters of the current fiscal year.
Latest events from Brady
- Record EPS, double-digit sales growth, and a $1.4B acquisition drive strong outlook.BRC
Q3 202622 May 2026 - Record adjusted EPS, 11.4% sales growth, and tighter guidance amid tariff and margin pressures.BRC
Q3 202518 May 2026 - Record EPS, strong cash flow, and Gravotech acquisition support continued growth.BRC
Q4 202418 May 2026 - Q2 FY2025 Adjusted EPS up 7.5%, guidance raised, strong cash flow and margin pressure.BRC
Q2 202518 May 2026 - Adjusted EPS up 12% and sales up 13.6%, with guidance reaffirmed for fiscal 2025.BRC
Q1 202518 May 2026 - $1.4B deal expands portfolio, adds $9B TAM, and targets $25M synergies and strong EPS accretion.BRC
M&A announcement20 Apr 2026 - Raised EPS guidance after strong sales, profit, and cash flow growth; 20th straight organic gain.BRC
Q2 202613 Apr 2026 - Record earnings, robust innovation, and global expansion drive strong long-term growth outlook.BRC
Sidoti March Small-Cap Virtual Conference19 Mar 2026 - Record profitability and innovation drive growth, supported by strong cash flow and global expansion.BRC
Small-Cap Growth Virtual Investor Conference3 Feb 2026